Ubs Asset Management Americas Inc Nuvalent, Inc. Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Nuvalent, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 149,941 shares of NUVL stock, worth $12.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
149,941
Previous 137,818
8.8%
Holding current value
$12.2 Million
Previous $10.8 Million
1.44%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding NUVL
# of Institutions
216Shares Held
60.9MCall Options Held
319KPut Options Held
211K-
Deerfield Management Company, L.P. (Series C) New York, NY18MShares$1.46 Billion32.3% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY5.27MShares$429 Million19.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$361 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.02MShares$246 Million0.01% of portfolio
-
Commodore Capital LP New York, NY1.86MShares$151 Million12.88% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $3.5B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...